financetom
Business
financetom
/
Business
/
Dentsply Sirona Reviewing Options for Wellspect Healthcare Business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dentsply Sirona Reviewing Options for Wellspect Healthcare Business
Feb 11, 2025 6:29 AM

09:02 AM EST, 02/11/2025 (MT Newswires) -- Dentsply Sirona ( XRAY ) said Tuesday that it is evaluating "strategic alternatives" for its Wellspect Healthcare business.

The review process has no set timetable and there is no assurance it will result in a transaction, the company said.

The company's shares were up more than 2% in recent premarket activity Tuesday.

Price: 18.92, Change: +0.46, Percent Change: +2.5

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla shares rebound as Musk-Trump row shows signs of cooling
Tesla shares rebound as Musk-Trump row shows signs of cooling
Jun 6, 2025
(Reuters) -Tesla shares clawed back from steep losses on Friday, as a war of words between CEO Elon Musk and U.S. President Donald Trump appeared to cool amid report that White House aides were scheduling a call to help broker peace. Shares were up 5% in premarket trading after Musk signalled on X he was open to easing tensions with...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ozempic, Wegovy may cause rare eye condition, EMA says
Ozempic, Wegovy may cause rare eye condition, EMA says
Jun 6, 2025
June 6 (Reuters) - The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very rare side effect of Novo Nordisk's popular treatments Ozempic and Wegovy, it said on Friday. The condition may affect up to 1 in 10,000 people taking semaglutide, the chemical name for Wegovy and Ozempic, the EMA said. ...
Amazon Vows to Curb Fake Reviews, UK Competition Watchdog Says
Amazon Vows to Curb Fake Reviews, UK Competition Watchdog Says
Jun 6, 2025
06:15 AM EDT, 06/06/2025 (MT Newswires) -- Amazon.com ( AMZN ) has vowed to enhance its systems to tackle fake reviews on its online marketplace, the UK Competition and Markets Authority said Friday. The e-commerce giant's undertakings tackle the competition watchdog's concerns regarding catalogue abuse, the CMA said. This is where sellers hijack the reviews of well-performing products and add...
Copyright 2023-2026 - www.financetom.com All Rights Reserved